MATURE B-CELL LEUKEMIA BURKITT-TYPE

Clinical trials for MATURE B-CELL LEUKEMIA BURKITT-TYPE explained in plain language.

Never miss a new study

Get alerted when new MATURE B-CELL LEUKEMIA BURKITT-TYPE trials appear

Sign up with your email to follow new studies for MATURE B-CELL LEUKEMIA BURKITT-TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for kids with aggressive blood cancers: adding a targeted drug to standard chemo

Disease control Completed

This trial tested whether adding a targeted drug called rituximab to standard chemotherapy could improve survival for children and adolescents with high-risk B-cell lymphoma or leukemia. It involved 482 young patients aged 6 months to 18 years with advanced disease. The main goal…

Matched conditions: MATURE B-CELL LEUKEMIA BURKITT-TYPE

Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

MATURE B-CELL LEUKEMIA BURKITT-TYPE

Get alerted when new MATURE B-CELL LEUKEMIA BURKITT-TYPE trials appear

New hope for kids with aggressive blood cancers: adding a targeted drug to standard chemo